[Federal Register Volume 87, Number 24 (Friday, February 4, 2022)]
[Notices]
[Pages 6615-6616]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2022-02330]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


Center for Scientific Review; Notice of Closed Meetings

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended, notice is hereby given of the following meetings.
    The meetings will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose

[[Page 6616]]

confidential trade secrets or commercial property such as patentable 
material, and personal information concerning individuals associated 
with the grant applications, the disclosure of which would constitute a 
clearly unwarranted invasion of personal privacy.

    Name of Committee: Oncology 2--Translational Clinical Integrated 
Review Group; Clinical Oncology Study Section.
    Date: February 28-March 1, 2022.
    Time: 9:00 a.m. to 8:30 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, Rockledge II, 6701 
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
    Contact Person: Laura Asnaghi, Ph.D., Scientific Review Officer, 
National Institute of Health, Center for Scientific Review, 6701 
Rockville Drive, Room 6200, MSC 7804, Bethesda, MD 20892, (301) 443-
1196, [email protected].

    Name of Committee: Healthcare Delivery and Methodologies 
Integrated Review Group; Healthcare and Health Disparities Study 
Section.
    Date: March 3-4, 2022.
    Time: 9:00 a.m. to 8:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, Rockledge II, 6701 
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
    Contact Person: Jessica Bellinger, Ph.D., Scientific Review 
Officer, Center for Scientific of Review, National Institutes of 
Health, 6701 Rockledge Drive, Room 3158, Bethesda, MD 20892, 301-
827-4446, [email protected].

    Name of Committee: Center for Scientific Review Special Emphasis 
Panel; Fellowships: Risks, Prevention and Health Behavior.
    Date: March 3-4, 2022.
    Time: 9:00 a.m. to 8:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, Rockledge II, 6701 
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
    Contact Person: Martha M. Faraday, Ph.D., Scientific Review 
Officer, Center for Scientific Review, National Institutes of 
Health, 6701 Rockledge Drive, Room 3110, MSC 7808, Bethesda, MD 
20892, (301) 435-3575, [email protected].

    Name of Committee: Risk, Prevention and Health Behavior 
Integrated Review Group; Lifestyle Change and Behavioral Health 
Study Section.
    Date: March 3-4, 2022.
    Time: 9:30 a.m. to 8:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, Rockledge II, 6701 
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
    Contact Person: Pamela Jeter, Ph.D., Scientific Review Officer, 
Center for Scientific Review, National Institute of Health, 6701 
Rockledge Drive, Room 10J08, Bethesda, MD 20892, (301) 827-6401, 
[email protected].

    Name of Committee: Center for Scientific Review Special Emphasis 
Panel; PAR21-326: Modern Equipment for Shared-Use Biomedical 
Research Facilities: Advancing Research-Related Operations.
    Date: March 3-4, 2022.
    Time: 10:00 a.m. to 8:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, Rockledge II, 6701 
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
    Contact Person: Jonathan Michael Peterson, Ph.D., Scientific 
Review Officer, Center for Scientific Review, National Institutes of 
Health, 6701 Rockledge Drive, Bethesda, MD 20892, (301) 867-5309, 
[email protected].

    Name of Committee: Cell Biology Integrated Review Group; 
Cellular Signaling and Regulatory Systems Study Section.
    Date: March 3-4, 2022.
    Time: 10:00 a.m. to 8:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, Rockledge II, 6701 
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
    Contact Person: David Balasundaram, Ph.D., Scientific Review 
Officer, Center for Scientific Review, National Institutes of 
Health, 6701 Rockledge Drive, Room 5189, MSC 7840, Bethesda, MD 
20892, 301-435-1022, [email protected].

    Name of Committee: Center for Scientific Review Special Emphasis 
Panel; Member Conflict: Motivated Behavior, Alcohol and 
Neurotoxicology.
    Date: March 9, 2022.
    Time: 11:00 a.m. to 7:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, Rockledge II, 6701 
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
    Contact Person: Michael Selmanoff, Ph.D., Scientific Review 
Officer, Center for Scientific Review, National Institutes of 
Health, 6701 Rockledge Drive, Room 5164, MSC 7844, Bethesda, MD 
20892, 301-435-1119, [email protected].

    Name of Committee: Center for Scientific Review Special Emphasis 
Panel; Member Conflict: Pain, Chemosensation and Sensory Motor 
Neurobiology.
    Date: March 10, 2022.
    Time: 10:30 a.m. to 7:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, Rockledge II, 6701 
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
    Contact Person: Roger Janz, Ph.D., Scientific Review Officer, 
Center for Scientific Review, National Institutes of Health, 6701 
Rockledge Drive, Bethesda, MD 20892, (301) 402-8515, 
[email protected].

    Name of Committee: Infectious Diseases and Immunology A 
Integrated Review Group; HIV Molecular Virology, Cell Biology, and 
Drug Development Study Section.
    Date: March 14-15, 2022.
    Time: 10:00 a.m. to 7:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, Rockledge II, 6701 
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
    Contact Person: Kenneth A. Roebuck, Ph.D., Scientific Review 
Officer, Center for Scientific Review, National Institutes of 
Health, 6701 Rockledge Drive, Room 5214, MSC 7852, Bethesda, MD 
20892, (301) 435-1166, [email protected].

    Name of Committee: Infectious Diseases and Immunology B 
Integrated Review Group; HIV Comorbidities and Clinical Studies 
Study Section.
    Date: March 15-16, 2022.
    Time: 9:00 a.m. to 8:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, Rockledge II, 6701 
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
    Contact Person: David C. Chang, Ph.D., Scientific Review 
Officer, Center for Scientific Review, National Institutes of 
Health, 6701 Rockledge Drive, Bethesda, MD 20892, (301) 451-0290, 
[email protected].

(Catalogue of Federal Domestic Assistance Program Nos. 93.306, 
Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333, 
93.337, 93.393-93.396, 93.837-93.844, 93.846-93.878, 93.892, 93.893, 
National Institutes of Health, HHS)

    Dated: January 31, 2022.
Miguelina Perez,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2022-02330 Filed 2-3-22; 8:45 am]
BILLING CODE 4140-01-P